Effects of Apatinib Mesylate Monotherapy on the Incidence of Adverse Reactions and Immune Function in Patients with Breast Cancer after Radical Mastectomy

OBJECTIVE: To assess the effects of monotherapy with apatinib mesylate on the incidence of adverse events and immune function in breast cancer patients after a radical mastectomy. METHODS: Between December 2018 and August 2020, 90 patients with breast cancer scheduled for a radical mastectomy in Peo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Sen, Zang, Meichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385297/
https://www.ncbi.nlm.nih.gov/pubmed/35990841
http://dx.doi.org/10.1155/2022/4022282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385297/
https://www.ncbi.nlm.nih.gov/pubmed/35990841
http://dx.doi.org/10.1155/2022/4022282

Ejemplares similares